Fresenius Medical Care’s heart & lung division Xenios AG is an expert in extracorporeal heart and lung support, specialized on products for extracorporeal membrane oxygenation (ECMO). ECMO treatment, used as “last rescue” procedure, is rarely performed on intensive care units (ICU) but mostly in so-called ECMO centers which are specialized in this form of treatment. Thus, intensive care physicians are often not familiar with this kind of treatment.
Therefore, there is a need to introduce physicians to this topic in a safe and easy-to-use digital environment. Virtual reality (VR) can help these physicians in getting first insights in ECMO treatment. With the help of VR goggles, procedures such as cannulation can be mimicked step-by-step, potentially overcoming existing hurdles.
Within a virtual ICU setting, Xenios shows a new perspective on ECMO treatments at ESICM LIVES congress in Paris. Based on a fictitious case, interested visitors can perform an ECMO procedure virtually with the use of VR googles or follow the simulation on a screen.
At Xenios, a Fresenius Medical Care company, we offer treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop intelligent technological solutions that can be vital for the survival of critically ill patients.
We offer solutions that combine both cardiac and pulmonary support on one single technological platform. It supports the gas exchange in the lungs and the cardiovascular system to keep patients alive. The physician thus gains more vital treatment time during diagnosis and therapy.
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people. For patients. Worldwide. Every day.
Visit the Xenios website:
www.xenios-ag.com
Xenios AG
Im Zukunftspark 1
74076 Heilbronn
Telefon: +49 (7131) 2706-0
Telefax: +49 (7131) 2706-299
http://www.xenios-ag.com
Communication Manager
Telefon: +49 (7131) 2706-388
Fax: +49 (7131) 2706-299
E-Mail: sandra.hubatschek@xenios-ag.com
